Skip to content

Clinical trials

Completed Alzheimer Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Completed Country / region: China Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20083
20102
20113
20123
20132
20142
20152
20163
20171
20181
20197
20204
20213
20225
20235
20245
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
XuanwuH 25
Capital Medical University3
Dongzhimen Hospital, Beijing3
Sinotau Pharmaceutical Group3
South China Center For Innovative Pharmaceuticals3
Anhui Medical University2
Beijing Friendship Hospital2
Novartis Pharmaceuticals2
Shanghai Hengrui Pharmaceutical Co., Ltd.2
Shanghai Mental Health Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease55
Cognitive Dysfunction13
Dementia8
Anxiety Disorders3
Brain Diseases2
Central Nervous System Diseases2
Mental Disorders2
Nervous System Diseases2
Neurodegenerative Diseases2
Tauopathies2

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.